INTRODUCTION: We describe a prototype positron projection imager (PPI) for visualizing the whole-body biodistribution of positron-emitting compounds in mouse-size animals. The final version of the PPI will be integrated into the MONICA portable dual-gamma camera system to allow the user to interchangeably image either single photon or positron-emitting compounds in a shared software and hardware environment. METHODS: A mouse is placed in the mid-plane between two identical, opposed, pixelated LYSO arrays separated by 21.8-cm and in time coincidence. An image of the distribution of positron decays in the animal is formed on this mid-plane by coincidence events that fall within a small cone angle perpendicular to the two detectors and within a user-specified energy window. We measured the imaging performance of this device with phantoms and in tests performed in mice injected with various compounds labeled with positron-emitting isotopes. RESULTS: Representative performance measurements yielded the following results (energy window 250-650keV, cone angle 3.5°): resolution in the image mid-plane, 1.66-mm (FWHM), resolution ±1.5-cm above and below the image plane, 2.2-mm (FWHM), sensitivity: 0.237-cps/kBq (8.76-cps/μCi) (18)F (0.024% absolute). Energy resolution was 15.9% with a linear-count-rate operating range of 0-14.8MBq (0-400μCi) and a corrected sensitivity variation across the field-of-view of <3%. Whole-body distributions of [(18)F] FDG and [(18)F] fluoride were well visualized in mice of typical size. CONCLUSION: Performance measurements and field studies indicate that the PPI is well suited to whole-body positron projection imaging of mice. When integrated into the MONICA gamma camera system, the PPI may be particularly useful early in the drug development cycle where, like MONICA, basic whole-body biodistribution data can direct future development of the agent under study and where logistical factors (e.g., available imaging space, non-portability, and cost) may be limitations. Published by Elsevier Inc.
INTRODUCTION: We describe a prototype positron projection imager (PPI) for visualizing the whole-body biodistribution of positron-emitting compounds in mouse-size animals. The final version of the PPI will be integrated into the MONICA portable dual-gamma camera system to allow the user to interchangeably image either single photon or positron-emitting compounds in a shared software and hardware environment. METHODS: A mouse is placed in the mid-plane between two identical, opposed, pixelated LYSO arrays separated by 21.8-cm and in time coincidence. An image of the distribution of positron decays in the animal is formed on this mid-plane by coincidence events that fall within a small cone angle perpendicular to the two detectors and within a user-specified energy window. We measured the imaging performance of this device with phantoms and in tests performed in mice injected with various compounds labeled with positron-emitting isotopes. RESULTS: Representative performance measurements yielded the following results (energy window 250-650keV, cone angle 3.5°): resolution in the image mid-plane, 1.66-mm (FWHM), resolution ±1.5-cm above and below the image plane, 2.2-mm (FWHM), sensitivity: 0.237-cps/kBq (8.76-cps/μCi) (18)F (0.024% absolute). Energy resolution was 15.9% with a linear-count-rate operating range of 0-14.8MBq (0-400μCi) and a corrected sensitivity variation across the field-of-view of <3%. Whole-body distributions of [(18)F] FDG and [(18)F] fluoride were well visualized in mice of typical size. CONCLUSION: Performance measurements and field studies indicate that the PPI is well suited to whole-body positron projection imaging of mice. When integrated into the MONICA gamma camera system, the PPI may be particularly useful early in the drug development cycle where, like MONICA, basic whole-body biodistribution data can direct future development of the agent under study and where logistical factors (e.g., available imaging space, non-portability, and cost) may be limitations. Published by Elsevier Inc.
Authors: Raymond R Raylman; Stan Majewski; Mark F Smith; James Proffitt; William Hammond; Amarnath Srinivasan; John McKisson; Vladimir Popov; Andrew Weisenberger; Clifford O Judy; Brian Kross; Srikanth Ramasubramanian; Larry E Banta; Paul E Kinahan; Kyle Champley Journal: Phys Med Biol Date: 2008-01-10 Impact factor: 3.609
Authors: Wenze Xi; Jurgen Seidel; John W Kakareka; Thomas J Pohida; Diane E Milenic; James Proffitt; Stan Majewski; Andrew G Weisenberger; Michael V Green; Peter L Choyke Journal: Nucl Med Biol Date: 2010-04 Impact factor: 2.408
Authors: H Zhang; N T Vu; Q Bao; R W Silverman; B N Berry-Pusey; A Douraghy; D A Williams; F R Rannou; D B Stout; A F Chatziioannou Journal: IEEE Trans Nucl Sci Date: 2010-06-01 Impact factor: 1.679
Authors: Mikako Ogawa; Celeste A S Regino; Jurgen Seidel; Michael V Green; Wenze Xi; Mark Williams; Nobuyuki Kosaka; Peter L Choyke; Hisataka Kobayashi Journal: Bioconjug Chem Date: 2009-11 Impact factor: 4.774
Authors: Michael V Green; Jurgen Seidel; Mark R Williams; Karen J Wong; Anita Ton; Falguni Basuli; Peter L Choyke; Elaine M Jagoda Journal: Nucl Med Biol Date: 2017-06-30 Impact factor: 2.408